c-met mAbs (A-CUBE)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namec-met mAbs (A-CUBE)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionHepatocyte growth factor receptor modulators
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsMacular DegenerationDiabetic RetinopathyNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesA-CUBE Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesA-CUBE Inc
Active IndicationsN/A
Inactive IndicationsMacular DegenerationDiabetic RetinopathyNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A